MAPT and Alzheimer disease: It has been previously shown that both UPS and ALP contribute to the degradation of tau aggregation in AD (Cheng et al., 2018), and there are also data that indicate the promotive effects of PINK1 on ALP (Michiorri et al., 2010; Parganlija et al., 2014; Du et al., 2017).